Regeneron Adds Hearing Loss Gene Therapy Program Via Decibel Therapeutics Acquisition
Regeneron Pharmaceuticals completed its acquisition of Decibel Therapeutics, strengthening the company’s gene therapy and auditory programs.
Tag: Decibel Therapeutics
All
Latest
All
Latest
Researchers Chart Development of Cells from Mouse Cochlea
In the future, scientists may be able to use the data to steer stem cells toward the hair cell lineage, helping to produce the specialized cells they need to test cell replacement approaches for reversing some forms of hearing loss.
All
Latest
GV Invests in Decibel Therapeutics
GV (formerly Google Ventures) has announced an investment into Decibel Therapeutics, which reportedly combines the companies' respective expertise to apply advanced big data sciences and analytics in the field of hearing. In conjunction with its equity investment, GV will contribute its significant technical expertise to Decibel. The amount of the investment was not disclosed.
